We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-0.05%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$17.5B
AUM Growth
-$4.53B
Cap. Flow
-$3.73B
Cap. Flow %
-21.26%
Top 10 Hldgs %
49.23%
Holding
203
New
48
Increased
29
Reduced
30
Closed
31

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$292M
2
KKR icon
KKR & Co
KKR
+$280M
3
ROIV icon
Roivant Sciences
ROIV
+$248M
4
MA icon
Mastercard
MA
+$138M
5
TMO icon
Thermo Fisher Scientific
TMO
+$133M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$650M
2
CYBR
CyberArk
CYBR
+$470M
3
CRM icon
Salesforce
CRM
+$334M
4
NDAQ icon
Nasdaq
NDAQ
+$290M
5
RNAM
Avidity Biosciences
RNAM
+$233M

Sector Composition

Rank Sector Weight
1 Healthcare 50.56%
2 Financials 12.21%
3 Technology 11.18%
4 Consumer Discretionary 5.09%
5 Industrials 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
176
Salesforce
CRM
$142B
– –
-1,261,177
Closed -$334M
CYBR
177
DELISTED
CyberArk
CYBR
– –
-1,053,040
Closed -$470M
DOCS icon
178
Doximity
DOCS
$3.91B
– –
-311,000
Closed -$13.8M
EDU icon
179
New Oriental
EDU
$7.84B
– –
-196,000
Closed -$10.8M
ESTA icon
180
Establishment Labs
ESTA
$2.75B
– –
-3,000
Closed -$219K
EXAS
181
DELISTED
Exact Sciences
EXAS
– –
-6,405,000
Closed -$650M
GPCR icon
182
Structure Therapeutics
GPCR
$3.34B
– –
-454,000
Closed -$31.6M
HYG icon
183
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.4B
– –
-8,000,000
Closed -$645M
IBIT icon
184
iShares Bitcoin Trust
IBIT
$47.9B
– –
-2,137,100
Closed -$106M
ICLR icon
185
Icon
ICLR
$12.8B
– –
-1,200
Closed -$219K
INSM icon
186
CALL
Insmed
INSM
$23.2B
– –
-250,000
Closed -$43.5M
INSM icon
187
Insmed
INSM
$23.2B
– –
-3,000
Closed -$522K
LLY icon
188
PUT
Eli Lilly
LLY
$1.02T
– –
-375,000
Closed -$403M
MLYS icon
189
Mineralys Therapeutics
MLYS
$2.35B
– –
-823,296
Closed -$29.9M
NDAQ icon
190
Nasdaq
NDAQ
$52B
– –
-2,989,213
Closed -$290M
NYT icon
191
New York Times
NYT
$12.2B
– –
-3,280,678
Closed -$228M
RNAM
192
DELISTED
Avidity Biosciences
RNAM
– –
-3,233,000
Closed -$233M
RSP icon
193
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$95.5B
– –
-3,600,000
Closed -$690M
SLNO
194
DELISTED
Soleno Therapeutics
SLNO
– –
-5,000
Closed -$232K
TRU icon
195
TransUnion
TRU
$15.2B
– –
-675,000
Closed -$57.9M
VSTM icon
196
Verastem
VSTM
$505M
– –
-2,000,000
Closed -$15.4M
DAY
197
DELISTED
Dayforce
DAY
– –
-2,925,000
Closed -$202M
ETH
198
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.73B
– –
-228,340
Closed -$6.41M
ETHA
199
iShares Ethereum Trust ETF
ETHA
$5.35B
– –
-1,481,001
Closed -$33.2M
SUNC
200
SunocoCorp LLC
SUNC
$3.84B
– –
-606,277
Closed -$29.9M
5 6 7
8
9

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Farallon Capital Management held 203 positions worth $17.5B, down 21% from $22.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Farallon Capital Management withdrew a net $3.73B in Q1 2026, closing 31 positions and reducing 30 holdings. Its most notable exit was Exact Sciences, an estimated $650M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 43% a quarter earlier, followed by Financials and Technology.

Against the trend, Farallon Capital Management opened a new position in Dianthus Therapeutics worth $70.2M.

  • Farallon Capital Management's largest Q1 2026 buy was Dianthus Therapeutics: 836,000 shares worth $70.2M.
  • Farallon Capital Management added most to Broadcom in Q1 2026, an estimated $292M increase.
  • Farallon Capital Management's biggest Q1 2026 reduction was Wabtec, cutting an estimated $210M.
  • Farallon Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $650M.
  • Farallon Capital Management's ten largest holdings make up 49% of its $17.5B portfolio in Q1 2026.
  • Farallon Capital Management opened 48 new positions and closed 31 in Q1 2026.
  • Farallon Capital Management's portfolio value fell 21% quarter-over-quarter to $17.5B.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.